Sheldon H - Search Results

1

Active involvement of Robo1 and Robo4 in filopodia formation and endothelial cell motility mediated via WASP and other actin nucleation-promoting factors.

Sheldon H, Andre M, Legg JA, Heal P, Herbert JM, Sainson R, Sharma AS, Kitajewski JK, Heath VL, Bicknell R. Sheldon H, et al. FASEB J. 2009 Feb;23(2):513-22. doi: 10.1096/fj.07-098269. Epub 2008 Oct 23. FASEB J. 2009. PMID: 18948384 Free PMC article.

2

Functionally defining the endothelial transcriptome, from Robo4 to ECSCR.

Verissimo AR, Herbert JM, Heath VL, Legg JA, Sheldon H, Andre M, Swain RK, Bicknell R. Verissimo AR, et al. Among authors: sheldon h. Biochem Soc Trans. 2009 Dec;37(Pt 6):1214-7. doi: 10.1042/BST0371214. Biochem Soc Trans. 2009. PMID: 19909249

3

New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes.

Sheldon H, Heikamp E, Turley H, Dragovic R, Thomas P, Oon CE, Leek R, Edelmann M, Kessler B, Sainson RC, Sargent I, Li JL, Harris AL. Sheldon H, et al. Blood. 2010 Sep 30;116(13):2385-94. doi: 10.1182/blood-2009-08-239228. Epub 2010 Jun 17. Blood. 2010. PMID: 20558614 Free article.

4

Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.

Mura M, Swain RK, Zhuang X, Vorschmitt H, Reynolds G, Durant S, Beesley JF, Herbert JM, Sheldon H, Andre M, Sanderson S, Glen K, Luu NT, McGettrick HM, Antczak P, Falciani F, Nash GB, Nagy ZS, Bicknell R. Mura M, et al. Among authors: sheldon h. Oncogene. 2012 Jan 19;31(3):293-305. doi: 10.1038/onc.2011.233. Epub 2011 Jun 27. Oncogene. 2012. PMID: 21706054

5

DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.

Li JL, Sainson RC, Oon CE, Turley H, Leek R, Sheldon H, Bridges E, Shi W, Snell C, Bowden ET, Wu H, Chowdhury PS, Russell AJ, Montgomery CP, Poulsom R, Harris AL. Li JL, et al. Among authors: sheldon h. Cancer Res. 2011 Sep 15;71(18):6073-83. doi: 10.1158/0008-5472.CAN-11-1704. Epub 2011 Jul 29. Cancer Res. 2011. PMID: 21803743

6

Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.

Oon CE, Bridges E, Sheldon H, Sainson RCA, Jubb A, Turley H, Leek R, Buffa F, Harris AL, Li JL. Oon CE, et al. Among authors: sheldon h. Oncotarget. 2017 Jun 20;8(25):40115-40131. doi: 10.18632/oncotarget.16969. Oncotarget. 2017. PMID: 28445154 Free PMC article.

7

Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.

Harjes U, Bridges E, Gharpure KM, Roxanis I, Sheldon H, Miranda F, Mangala LS, Pradeep S, Lopez-Berestein G, Ahmed A, Fielding B, Sood AK, Harris AL. Harjes U, et al. Among authors: sheldon h. Oncogene. 2017 Feb 16;36(7):912-921. doi: 10.1038/onc.2016.256. Epub 2016 Aug 29. Oncogene. 2017. PMID: 27568980 Free PMC article.

8

ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype.

Sheldon H, Alexander J, Bridges E, Moreira L, Reilly S, Ang KH, Wang D, Lin S, Haider S, Banham AH, Harris AL. Sheldon H, et al. Int J Mol Sci. 2021 Oct 19;22(20):11293. doi: 10.3390/ijms222011293. Int J Mol Sci. 2021. PMID: 34681953 Free PMC article.

9

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.

Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J. Camps C, et al. Among authors: sheldon h. Clin Cancer Res. 2008 Mar 1;14(5):1340-8. doi: 10.1158/1078-0432.CCR-07-1755. Clin Cancer Res. 2008. PMID: 18316553 Free article.

10

Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms.

Lowndes SA, Sheldon HV, Cai S, Taylor JM, Harris AL. Lowndes SA, et al. Microvasc Res. 2009 May;77(3):314-26. doi: 10.1016/j.mvr.2009.01.003. Epub 2009 Jan 27. Microvasc Res. 2009. PMID: 19323979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page